The cardiac‐specific RBP Hnrnpa1, which was identified by single‐cell omics, triggered daughter CM formation by promoting CM dedifferentiation and cell cycle activity in a post‐transcriptional manner, indicating that Hnrnpa1 is a promising therapeutic target for heart failure after MI. Here, HNRNPA1 is linked to heart failure.